Detalhe da pesquisa
1.
The Effect of Angiogenesis-Based Scaffold of MesoporousBioactive Glass Nanofiber on Osteogenesis.
Int J Mol Sci
; 23(20)2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293527
2.
PCL nanofibrous incorporating unique matrix fusion protein adsorbed mesoporous bioactive glass for bone tissue engineering.
Int J Biol Macromol
; 208: 136-148, 2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301005
3.
Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Eur J Pharm Biopharm
; 67(2): 464-75, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17451929
4.
Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit RS 30 D.
Eur J Pharm Biopharm
; 59(1): 147-54, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15567312
5.
A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
Int J Pharm
; 279(1-2): 127-39, 2004 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-15234801
6.
Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
Int J Pharm
; 367(1-2): 20-8, 2009 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-18848872
7.
Use of proteins to minimize the physical aging of EUDRAGIT sustained release films.
Drug Dev Ind Pharm
; 33(7): 717-26, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17654020
8.
Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets.
Drug Dev Ind Pharm
; 29(3): 357-66, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12741617